Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

AKARI THERAPEUTICS, PLC

Company number 05252842

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
11 Jun 2020 AA Group of companies' accounts made up to 31 December 2019
10 Jun 2020 CH01 Director's details changed for Dr Peter Feldschreiber on 22 August 2018
10 Jun 2020 CH01 Director's details changed for Michael Grissinger on 22 August 2018
28 May 2020 SH01 Statement of capital following an allotment of shares on 22 May 2020
  • GBP 29,478,955.13
28 May 2020 SH01 Statement of capital following an allotment of shares on 22 May 2020
  • GBP 28,878,955.13
06 Mar 2020 SH01 Statement of capital following an allotment of shares on 3 March 2020
  • GBP 28,728,955.13
28 Feb 2020 SH01 Statement of capital following an allotment of shares on 24 February 2020
  • GBP 26,776,019.13
13 Jan 2020 SH01 Statement of capital following an allotment of shares on 13 January 2020
  • GBP 23,108,659.13
09 Jan 2020 SH01 Statement of capital following an allotment of shares on 9 January 2020
  • GBP 22,608,659.13
27 Dec 2019 SH01 Statement of capital following an allotment of shares on 27 December 2019
  • GBP 22,458,659.13
27 Dec 2019 SH01 Statement of capital following an allotment of shares on 24 December 2019
  • GBP 22,308,659.13
23 Dec 2019 SH01 Statement of capital following an allotment of shares on 18 December 2019
  • GBP 22,158,659.13
20 Dec 2019 SH01 Statement of capital following an allotment of shares on 2 December 2019
  • GBP 22,008,659.13
01 Nov 2019 RP04AP01 Second filing for the appointment of Raymond Richard Prudo-Chlebosz as a director
01 Nov 2019 RP04AP01 Second filing for the appointment of Clive Stuart Richardson as a director
21 Oct 2019 SH01 Statement of capital following an allotment of shares on 16 October 2019
  • GBP 21,308,659.13
16 Oct 2019 CH01 Director's details changed for Stuart Charles Ungar on 5 April 2016
16 Oct 2019 CH01 Director's details changed for Mr Peter Feldschreiber on 29 August 2019
16 Oct 2019 CS01 Confirmation statement made on 7 October 2019 with updates
08 Oct 2019 SH01 Statement of capital following an allotment of shares on 26 September 2019
  • GBP 21,008,659.13
19 Sep 2019 SH01 Statement of capital following an allotment of shares on 18 September 2019
  • GBP 20,858,659.13
09 Sep 2019 TM02 Termination of appointment of Dov Elefant as a secretary on 9 September 2019
04 Sep 2019 RP04SH01 Second filing of a statement of capital following an allotment of shares on 15 August 2019
  • GBP 20,408,659.13
15 Aug 2019 SH01 Statement of capital following an allotment of shares on 14 August 2019
  • GBP 20,408,659.13
  • ANNOTATION Clarification a second filed SH01 was registered on 04/09/2019.
04 Jul 2019 SH01 Statement of capital following an allotment of shares on 2 July 2019
  • GBP 18,875,326.13